BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abu-Sbeih H, Mallepally N, Goldstein R, Chen E, Tang T, Dike UK, Al-Asadi M, Westin S, Halperin D, Wang Y. Gastrointestinal toxic effects in patients with cancer receiving platinum-based therapy. J Cancer 2020;11:3144-50. [PMID: 32231718 DOI: 10.7150/jca.37777] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Nielsen DL, Juhl CB, Chen IM, Kellermann L, Nielsen OH. Immune checkpoint Inhibitor–Induced diarrhea and Colitis: Incidence and Management. A systematic review and Meta-analysis. Cancer Treatment Reviews 2022;109:102440. [DOI: 10.1016/j.ctrv.2022.102440] [Reference Citation Analysis]
2 Zou Y, Liu S, Wu J, Sun Z. Severe ileum bleeding following adjuvant capecitabine chemotherapy for locally advanced colon cancer: a case report and review of the literature. World J Surg Oncol 2021;19:332. [PMID: 34809643 DOI: 10.1186/s12957-021-02443-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Yu Z, Huang R, Zhao L, Wang X, Shangguan X, Li W, Li M, Yin X, Zhang C, Liu D. Safety Profile of Oxaliplatin in 3,687 Patients With Cancer in China: A Post-Marketing Surveillance Study. Front Oncol 2021;11:757196. [PMID: 34745993 DOI: 10.3389/fonc.2021.757196] [Reference Citation Analysis]
4 Yuan W, Xiao X, Yu X, Xie F, Feng P, Malik K, Wu J, Ye Z, Zhang P, Li X. Probiotic Therapy (BIO-THREE) Mitigates Intestinal Microbial Imbalance and Intestinal Damage Caused by Oxaliplatin. Probiotics Antimicrob Proteins 2021. [PMID: 33956306 DOI: 10.1007/s12602-021-09795-3] [Reference Citation Analysis]